Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Enzon Inc (QB) ENZN

Healthcare Biotechnology
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

Current News (OTCQB:ENZN)

Enzon and Viskase Announce Amendment to Merger Agreement

GlobeNewswire October 24, 2025

Enzon and Viskase Enter into Merger Agreement

GlobeNewswire June 20, 2025

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO

GlobeNewswire January 4, 2021

Enzon Pharmaceuticals Announces Results of Rights Offering

GlobeNewswire October 21, 2020

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

GlobeNewswire September 15, 2020

Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

GlobeNewswire September 2, 2020

Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

GlobeNewswire August 21, 2020

Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

GlobeNewswire August 14, 2020

Icahn's (Potential) Move Into Biotech

Benzinga.com  March 4, 2017
View More News ››

Opinion & Analysis (OTCQB:ENZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:ENZN)

Enzon pharma loss 7% to 0,666$ from high record 66,6$ short

Enzon pharma on a roller coaster trend from high record over 60$ down below a buck, what is going on ? Short-selling system sometime is...
peterfriday - November 1, 2015

more than $1 from Mar 12- Apr 1st.

if Enzon was better at maximizing its true potential, the stock could easily vault from its current undervalued state and generate some...
mart33 - April 8, 2008

Icahn pushes to sell but stock maybe a buy

Enzon Pharmaceuticals (ENZN) announces that PEG-SN38 is featured in the March 15th issue of Clinical Cancer Research published by the...
mart33 - March 24, 2008

as above

For a great thread look up Yahoo(USA) quotes and latch on to the tread and give it a yank.Good luck.
Levis - March 10, 2000

Enzon

Anyone on this board follow this stock? Opinions welcome. Would love to get an active board going here on ENZN, it is a most...
estherbye - August 31, 1999
View more Bullboard ››

Lomiko Metals Inc.

Lomiko Metals Inc.

Lomiko Metals Inc. is a Canada-based company developing its flagship graphite property, La Loutre graphite in southern Quebec ...
View More »

Podcasts